# Fresenius Kabi USA, LLC: Carboplatin Injection shortage reverified (unavailable from this maker)

**Score:** 55/100

| Field | Value |
|---|---|
| Manufacturer | Fresenius Kabi USA, LLC |
| Drug | Carboplatin Injection |
| Dosage form | Injection |
| Therapeutic category | Oncology |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Unavailable |
| Reason | Delay in shipping of the drug |
| Presentations affected | 1 |
| Package NDCs | 63323-172-60 |
| Manufacturer supply note | Next release December 2026. Check wholesalers for inventory. |
| First posted | 2023-04-28 |
| Updated | 2026-11-03 |

## Why this score
- Unavailable from this manufacturer.
- Sterile injectable: hospital and 503B demand.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-05T09:00:14.778Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.